Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Salivary peptide/protein-based multilayer denture coatings for controlling Candida biofilm formation and denture stomatitis

Award Number: R01DE034121
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2024
PERIOD OF PERFORMANCE END DATE: 04/30/2028

Group Awards By:

View Award Description

Salivary peptide/protein-based multilayer denture coatings for controlling Candida biofilm formation and denture stomatitis - Project Summary/Abstract: Candida-associated denture stomatitis (CADS), due to Candida colonization and biofilm formation on the denture surface, is a significant clinical concern and affects up to 67% of denture wearers. Fungal biofilms serve as a reservoir for various oral bacteria that cause oral health problems and systemic infections. Currently, strategies for controlling CADS are clinically challenging and have high reinfection rates, particularly in elderly and/or immunologically- or medically-compromised patients. This proposal is being submitted in response to NIDCR RFA-DE-24-004 and aims to use natural salivary anticandidal peptides/proteins in multilayer coatings on dentures to control CADS. We have previously demonstrated that covalently binding functional polymers, such as poly(methacrylic acid) (PMAA), onto conventional dentures enhances the binding of cationic anticandidal biomolecules, including histatin 5 (H-5), a major salivary polypeptide of the histatin family with high anticandidal activity. The PMAA functionalized denture material maintained the physical/mechanical properties of the original resin. We have further used a layer-by- layer (LBL) self-assembly technology (alternating the deposition of oppositely charged polyelectrolytes) by pairing H-5 with hyaluronic acid (HA), an anionic unsulfated salivary glycosaminoglycan, to form H-5/HA multilayer coatings, resulting in an increase in the H-5 content on the surface of the denture material. Using H-5 as the outermost layer, the LBL self-assembled H-5/HA multilayer coatings inhibited Candida adhesion and had long-lasting (weeks to months) anticandidal effects that blocked Candida biofilm formation. The LBL coatings were stable and remained on the denture surface after extensive mechanical brushing (e.g., >20,000 cycles of brushing). The long-term goal of this project is to use normal salivary components as natural and safe antifungal therapeutics for controlling Candida biofilm formation and managing CADS. The main objectives of this proposal are to evaluate the efficacy of salivary anticandidal peptides/proteins in multilayer coatings for controlling Candida biofilm formation on rat dentures and in a novel rat denture stomatitis model. The specific aims of the proposed research are: (1) to fabricate rat dentures with salivary anticandidal peptide/protein-based LBL multilayer coatings; (2) to evaluate the anticandidal activity and biocompatibility of the functionalized and coated dentures in vitro; and (3) to evaluate the preclinical efficacy of the dentures coated with salivary anticandidal peptide/protein multilayers in vitro and in vivo. If successful, this new denture technology will be the first therapeutic denture using natural salivary components to provide a long-term biofilm-controlling effects, prevent unnecessary drug exposure, and minimize the risk of developing Candida resistance. These anticandidal technologies will not only have a significant impact on clinical dentistry but may also provide new materials for a variety of medical devices (e.g., catheters, endotracheal tubes) and reduce hospital-acquired infections.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $630,675 )
2026	2026	UNIVERSITY OF MASSACHUSETTS LOWELL	220 PAWTUCKET ST STE 400	LOWELL	MA	01854	MIDDLESEX	USA	Oral Diseases and Disorders Research	000	3	4/24/2026	NON-COMPETING CONTINUATION	$630,675
														Subtotal = $630,675

Issue Date FY: 2025 ( Subtotal = $630,675 )
2025	2025	UNIVERSITY OF MASSACHUSETTS LOWELL	220 PAWTUCKET ST STE 400	LOWELL	MA	01854	MIDDLESEX	USA	Oral Diseases and Disorders Research	000	2	4/3/2025	NON-COMPETING CONTINUATION	$567,607
2025	2025	UNIVERSITY OF MASSACHUSETTS LOWELL	220 PAWTUCKET ST STE 400	LOWELL	MA	01854	MIDDLESEX	USA	Oral Diseases and Disorders Research	001	2	5/8/2025	NON-COMPETING CONTINUATION	$63,068
														Subtotal = $630,675

Issue Date FY: 2024 ( Subtotal = $644,760 )
2024	2024	UNIVERSITY OF MASSACHUSETTS LOWELL	600 SUFFOLK ST STE 450	LOWELL	MA	01854	MIDDLESEX	USA	Oral Diseases and Disorders Research	000	1	7/31/2024	NEW	$644,760
														Subtotal = $644,760

Grand Total All Awards = $1,906,110

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Salivary peptide/protein-based multilayer denture coatings for controlling Candida biofilm formation and denture stomatitis

Award Number: R01DE034121

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2024

PERIOD OF PERFORMANCE END DATE: 04/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer